Raffaele Nardone , Luca Sebastianelli , Patrick B. Langthaler , Kerstin Schwenker , Eugen Trinka , Viviana Versace
{"title":"Altered cortical plasticity but preserved cholinergic transmission in HIV-associated dementia: A TMS study","authors":"Raffaele Nardone , Luca Sebastianelli , Patrick B. Langthaler , Kerstin Schwenker , Eugen Trinka , Viviana Versace","doi":"10.1016/j.clinph.2025.2111369","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>We used transcranial magnetic stimulation (TMS) to examine whether short-latency afferent inhibition (SAI)—a marker of cholinergic transmission—and long-term potentiation (LTP)-like cortical plasticity via paired associative stimulation (PAS25) are affected in patients with HIV-associated dementia (HAD).</div></div><div><h3>Methods</h3><div>Seventeen HAD and 17 age-matched healthy controls (HCs) underwent SAI assessment; 15 subjects per group also completed PAS25. Resting motor threshold (RMT) and motor evoked potentials (MEPs) were recorded. SAI was measured as the ratio of conditioned to unconditioned MEPs, using peripheral stimulation followed by motor cortex TMS. PAS25 consisted of 180 paired peripheral–cortical stimuli at 0.2 Hz; MEPs were recorded at baseline, 0, 15, and 30 min (T0, T15, T30) post-intervention.</div></div><div><h3>Results</h3><div>RMT and SAI did not differ between HAD and HCs (RMT: 54.0 ± 7.8 vs. 50.7 ± 6.1; SAI: 46.9 ± 8.6 % vs. 44.9 ± 5.3 %). PAS25 significantly increased MEPs amplitude in HCs at all timepoints (RTEs: T0 = 0.76, T15 = 0.87, T30 = 0.80), but not in HAD (T0 = 0.31, T15 = 0.29, T30 = 0.26).</div></div><div><h3>Conclusions</h3><div>In HAD, cholinergic activity is preserved in motor cortex, while glutamate-dependent LTP-like plasticity is impaired.</div></div><div><h3>Significance</h3><div>SAI and PAS25 are complementary neurophysiological tools distinguishing HAD from Alzheimer’s disease.</div></div>","PeriodicalId":10671,"journal":{"name":"Clinical Neurophysiology","volume":"179 ","pages":"Article 2111369"},"PeriodicalIF":3.6000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurophysiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1388245725012210","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
We used transcranial magnetic stimulation (TMS) to examine whether short-latency afferent inhibition (SAI)—a marker of cholinergic transmission—and long-term potentiation (LTP)-like cortical plasticity via paired associative stimulation (PAS25) are affected in patients with HIV-associated dementia (HAD).
Methods
Seventeen HAD and 17 age-matched healthy controls (HCs) underwent SAI assessment; 15 subjects per group also completed PAS25. Resting motor threshold (RMT) and motor evoked potentials (MEPs) were recorded. SAI was measured as the ratio of conditioned to unconditioned MEPs, using peripheral stimulation followed by motor cortex TMS. PAS25 consisted of 180 paired peripheral–cortical stimuli at 0.2 Hz; MEPs were recorded at baseline, 0, 15, and 30 min (T0, T15, T30) post-intervention.
Results
RMT and SAI did not differ between HAD and HCs (RMT: 54.0 ± 7.8 vs. 50.7 ± 6.1; SAI: 46.9 ± 8.6 % vs. 44.9 ± 5.3 %). PAS25 significantly increased MEPs amplitude in HCs at all timepoints (RTEs: T0 = 0.76, T15 = 0.87, T30 = 0.80), but not in HAD (T0 = 0.31, T15 = 0.29, T30 = 0.26).
Conclusions
In HAD, cholinergic activity is preserved in motor cortex, while glutamate-dependent LTP-like plasticity is impaired.
Significance
SAI and PAS25 are complementary neurophysiological tools distinguishing HAD from Alzheimer’s disease.
期刊介绍:
As of January 1999, The journal Electroencephalography and Clinical Neurophysiology, and its two sections Electromyography and Motor Control and Evoked Potentials have amalgamated to become this journal - Clinical Neurophysiology.
Clinical Neurophysiology is the official journal of the International Federation of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, the Italian Clinical Neurophysiology Society and the International Society of Intraoperative Neurophysiology.The journal is dedicated to fostering research and disseminating information on all aspects of both normal and abnormal functioning of the nervous system. The key aim of the publication is to disseminate scholarly reports on the pathophysiology underlying diseases of the central and peripheral nervous system of human patients. Clinical trials that use neurophysiological measures to document change are encouraged, as are manuscripts reporting data on integrated neuroimaging of central nervous function including, but not limited to, functional MRI, MEG, EEG, PET and other neuroimaging modalities.